• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性宫颈癌发病率支持两种病因学成分:基于人群的登记研究。

Age-related incidence of cervical cancer supports two aetiological components: a population-based register study.

机构信息

Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.

Department of Public Health, University of Helsinki, Helsinki, Finland.

出版信息

BJOG. 2016 Apr;123(5):772-8. doi: 10.1111/1471-0528.13754. Epub 2015 Nov 24.

DOI:10.1111/1471-0528.13754
PMID:26599730
Abstract

OBJECTIVE

To assess whether age-related incidence of cervical cancer supports two aetiological components and to assess trends in these components due to risk factors and to organised screening in Finland.

DESIGN

Population-based register study.

SETTING

Finnish Cancer Registry.

POPULATION

Cervical cancer cases and female population in Finland in 1953-2012.

METHODS

Cervical cancer incidence was estimated using Poisson regression where age-specific incidence consists of two (early-age and late-age) normally distributed components.

MAIN OUTCOME MEASURES

Accumulated net risks (incidences) and numbers of cancer cases attributed to each age-related component by calendar time.

RESULTS

The accumulated cervical cancer incidence in 2008-2012 was only 30% of that in 1953-1962, before the screening started. The fit of the observed age-specific rates and the rates based on the two-component model was good. In 1953-62, the accumulated net risk ratio (RR; early-age versus late-age) was 0.42 (95% CI 0.29-0.61). The early-age component disappeared in 1973-77 (RR 0.00; 95% CI 0.00-0.08). Thereafter, the risk for the early-age component increased, whereas the risk for the late-age component decreased, and in 2008-2012 the RR was 0.55 (95% CI 0.24-0.89).

CONCLUSIONS

In Finland, cervical cancer incidence has two age-related components which are likely to indicate differences in risk factors of each component. The trend in risk of both components followed the effects of organised screening. Furthermore, the risk related to the early-age component followed changes in risk factors, such as oncogenic HPV infections and other sexually transmitted diseases and smoking habits.

TWEETABLE ABSTRACT

Cervical cancer incidence has two age-related components which are likely to have differencies in their aetiology.

摘要

目的

评估宫颈癌的年龄相关性发病是否支持两个病因学组成部分,并评估由于危险因素和芬兰有组织筛查而导致这些组成部分的趋势。

设计

基于人群的登记研究。

地点

芬兰癌症登记处。

人群

1953-2012 年芬兰的宫颈癌病例和女性人群。

方法

使用泊松回归估计宫颈癌发病率,其中年龄特异性发病率由两个(早龄和老龄)正态分布组成部分组成。

主要观察指标

按日历时间累积的净风险(发病率)和归因于每个与年龄相关的组成部分的癌症病例数。

结果

在筛查开始之前,2008-2012 年累积宫颈癌发病率仅为 1953-1962 年的 30%。观察到的年龄特异性率与基于两成分模型的率拟合良好。1953-62 年,累积净风险比(早期年龄与老龄)为 0.42(95%CI 0.29-0.61)。1973-77 年早期年龄成分消失(RR 0.00;95%CI 0.00-0.08)。此后,早期年龄成分的风险增加,而老龄成分的风险降低,2008-2012 年 RR 为 0.55(95%CI 0.24-0.89)。

结论

在芬兰,宫颈癌的发病率有两个与年龄相关的组成部分,这可能表明每个组成部分的危险因素不同。两个组成部分的风险趋势都遵循有组织筛查的效果。此外,与早期年龄成分相关的风险与致癌 HPV 感染和其他性传播疾病以及吸烟习惯等危险因素的变化有关。

推文摘要

宫颈癌的发病率有两个与年龄相关的组成部分,这些组成部分的病因可能不同。

相似文献

1
Age-related incidence of cervical cancer supports two aetiological components: a population-based register study.年龄相关性宫颈癌发病率支持两种病因学成分:基于人群的登记研究。
BJOG. 2016 Apr;123(5):772-8. doi: 10.1111/1471-0528.13754. Epub 2015 Nov 24.
2
Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population.芬兰和爱沙尼亚宫颈癌的发病率和死亡率趋势:筛查人群与未筛查人群对比
Eur J Cancer. 1993;29A(5):745-9. doi: 10.1016/s0959-8049(05)80359-4.
3
Occupational exposures and cancers of the endometrium and cervix uteri in Finland.芬兰的职业暴露与子宫内膜癌和子宫颈癌
Am J Ind Med. 2001 Jun;39(6):572-80. doi: 10.1002/ajim.1056.
4
Epidemiological evidence for two components of cervical cancer.宫颈癌两个组成部分的流行病学证据。
Br J Obstet Gynaecol. 1981 Mar;88(3):209-14. doi: 10.1111/j.1471-0528.1981.tb00970.x.
5
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.1963年至1995年芬兰有组织筛查对宫颈癌发病率和死亡率的影响:近期宫颈癌发病率上升
Int J Cancer. 1999 Sep 24;83(1):59-65. doi: 10.1002/(sici)1097-0215(19990924)83:1<59::aid-ijc12>3.0.co;2-n.
6
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.芬兰和荷兰的宫颈癌大规模筛查计划及趋势
Int J Cancer. 2008 Apr 15;122(8):1854-8. doi: 10.1002/ijc.23276.
7
Risk of cervical cancer after a negative Pap smear.巴氏涂片检查结果为阴性后患宫颈癌的风险。
J Med Screen. 1999;6(2):103-7. doi: 10.1136/jms.6.2.103.
8
Pap test use and cervical cancer incidence in First Nations women living in Manitoba.居住在曼尼托巴省的原住民妇女的巴氏试验使用情况与宫颈癌发病率
Cancer Prev Res (Phila). 2015 Jan;8(1):49-55. doi: 10.1158/1940-6207.CAPR-14-0277. Epub 2014 Nov 17.
9
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.104760例宫颈癌幸存者中的二次癌症:长期风险评估
J Natl Cancer Inst. 2007 Nov 7;99(21):1634-43. doi: 10.1093/jnci/djm201. Epub 2007 Oct 30.
10
On Exploring Hidden Structures Behind Cervical Cancer Incidence.探索宫颈癌发病率背后的隐藏结构
Cancer Control. 2018 Jan-Dec;25(1):1073274818801604. doi: 10.1177/1073274818801604.

引用本文的文献

1
Knowledge about HPV Infection and the HPV Vaccine among Parents in Southeastern Serbia.HPV 感染和 HPV 疫苗在塞尔维亚东南部父母中的认知。
Medicina (Kaunas). 2022 Nov 22;58(12):1697. doi: 10.3390/medicina58121697.
2
Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.宫颈癌的发生、化疗耐药及其治疗:miRNA 参与的一个快照。
Mol Cell Biochem. 2021 Dec;476(12):4363-4385. doi: 10.1007/s11010-021-04249-4. Epub 2021 Aug 28.
3
Risk factors for precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: Unmatched case-control study.
埃塞俄比亚南部宫颈癌筛查女性中癌前宫颈病变的危险因素:病例对照研究。
PLoS One. 2021 Jul 15;16(7):e0254663. doi: 10.1371/journal.pone.0254663. eCollection 2021.
4
Knowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia.塞尔维亚女学生对宫颈癌的认识和对人乳头瘤病毒(HPV)及 HPV 疫苗的认识。
Medicina (Kaunas). 2020 Aug 13;56(8):406. doi: 10.3390/medicina56080406.
5
RIPK1 polymorphisms alter the susceptibility to cervical Cancer among the Uyghur population in China.RIPK1 多态性改变了中国维吾尔族人群罹患宫颈癌的易感性。
BMC Cancer. 2020 Apr 9;20(1):299. doi: 10.1186/s12885-020-06779-4.
6
MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer.miR-4524b-5p/WTX/β-catenin 轴作为宫颈癌转移的调节剂。
PLoS One. 2019 Apr 2;14(4):e0214822. doi: 10.1371/journal.pone.0214822. eCollection 2019.
7
Effectiveness of cervical cancer screening at age 65 - A register-based cohort study.65 岁以上女性宫颈癌筛查效果的观察——一项基于注册登记的队列研究。
PLoS One. 2019 Mar 26;14(3):e0214486. doi: 10.1371/journal.pone.0214486. eCollection 2019.
8
On Exploring Hidden Structures Behind Cervical Cancer Incidence.探索宫颈癌发病率背后的隐藏结构
Cancer Control. 2018 Jan-Dec;25(1):1073274818801604. doi: 10.1177/1073274818801604.
9
MiR-142 inhibits the development of cervical cancer by targeting HMGB1.微小RNA-142通过靶向高迁移率族蛋白B1抑制宫颈癌的发展。
Oncotarget. 2017 Jan 17;8(3):4001-4007. doi: 10.18632/oncotarget.13136.